Blackbriar-LLC International Consulting Services

07/03/2026

📢 New international guidance is now available for the use of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists in people with Type 1 Diabetes.

Endorsed by and several leading diabetes organizations, the consensus provides practical recommendations to support clinicians in the safe and effective use of these therapies, including guidance on insulin adjustments, risk mitigation, and clinical decision-making.

The publication also reviews emerging evidence on the potential benefits of these treatments for people with Type 1 Diabetes, while highlighting areas where further research is needed.

📖 Read the publication: https://bit.ly/4gc2kBO

06/24/2026

05/22/2026

https://www.linkedin.com/posts/viadiabetes_via-diabetes-press-release-dm-stigma-and-activity-7462147893001420800-djs3?utm_medium=ios_app&rcm=ACoAAAA9hr8BON7dU7I1WFqWALOemK_dwHahyWk&utm_source=social_share_send&utm_campaign=copy_link

FOR IMMEDIATE RELEASE Voices in Action (VIA) Diabetes and our partners calls upon World Health Organization to act on diabetes related stigma and discrimination. 100 organizations have joined this call, alongside Fórum Intersetorial de CCNTs no Brasil, International Diabetes Federation, Parliamenta...

03/17/2026

Huge congratulations to Prof. Dr. Thomas Danne on receiving Children with Diabetes’ 2026 President’s Award for Innovation at Advanced Technologies & Treatments for Diabetes (ATTD) Barcelona!

This award honors leaders who are pushing diabetes care forward through innovation—and Dr. Danne’s impact truly speaks for itself. From advancing cutting-edge diabetes technologies to leading global collaboration in research and care, his work has helped shape the future for people living with type 1 diabetes around the world.

As Chief Medical Officer of Breakthrough T1D and a lifelong leader in pediatric diabetology, Dr. Danne has spent decades driving progress in insulin delivery, glucose monitoring, and therapies that help people with T1D not just live—but thrive.

We are honored to celebrate a leader whose dedication continues to change lives across the global T1D community. Thank you, Dr. Danne, for your vision, your leadership, and your unwavering commitment to improving life with diabetes.

03/13/2026

03/13/2026

Science working as it should…

HISTORY

Danish Physician Hans Christian Hagedorn discovers the action of insulin can be prolonged with the addition of protamine in 1936, which ultimately became known as NPH Insulin. This means that people with diabetes can have fewer injections. NPH insulin was not marketed and available until 1946.

02/10/2026

A wonderful recognition for a great guy…

🎉 We would like to congratulate again Professor Joseph Wolfsdorf, recipient of the ISPAD 2025 Prize for Achievement!

A global leader in pediatric diabetes, Prof. Wolfsdorf has dedicated over four decades to advancing care, education, and research.
Read more about his accomplishments: https://loom.ly/kVAd2YI

We are honored to recognize his remarkable impact on generations of healthcare professionals and young people with diabetes worldwide.

👏 Thank you to Eli Lilly for generously supporting this prestigious award.